Three-dimensional transvaginal ultrasound improves measurement of nuchal translucency

Journal of Perinatal Medicine

Volumn 27, Issue 2, 1999, Pages 97-102

  Kurjak, Asim ^a   Kupesic, Sanja ^a   Ivančić Košuta, Mirjana ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b Department of Anatomy   (Croatia)

Author keywords

Intra observer reproducibility; Nuchal translucency; Threedimensional; Transvaginal ultrasound; Two dimensional transvaginal ultrasound

Indexed keywords

ARTICLE; FEMALE; FETUS; HUMAN; NORMAL HUMAN; OBSERVER VARIATION; PRIORITY JOURNAL; REPRODUCIBILITY; STATISTICAL ANALYSIS; TRANSVAGINAL ECHOGRAPHY;

ADULT; CHROMOSOME ABERRATIONS; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; NECK; PREGNANCY; REPRODUCIBILITY OF RESULTS; ULTRASONOGRAPHY, PRENATAL; VAGINA;

EID: 0032945754     PISSN: 03005577     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPM.1999.011     Document Type: Article

References (18)

1. Bilardo CM, E Pajkrt, I de Graaf, BW Mol, OP Bleker: Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 11 (1998) 401
2. Braithwaite JM, DL Economides: The measurement of nuchal translucency with transabdominal and transvaginal sonography - success rates, repeatability and level of agreement. Br J Obstet Gynaecol 68 (1995) 720
3. Haddow JE, GE Palomokie: Down's syndrome screening. Lancet 347 (1996) 1625
4. Herman A, R Maymon, E Dreazen, E Caspi, E Bukovsky, Z Weiseraub: Image magnification does not contribute to the repeatibility of caliper placement in measuring nuchal translucency thickness. Ultrasound Obstet Gynecol 11 (1998) 266
5. Kadir RL, DL Economides: The effect of nuchal translucency measurement on second trimester biochemical screening for Down's syndrome. Ultrasound Obstet Gynecol 9 (1997) 244
6. Kornman LH, LP Morssink, JR Beekhuis, BT De Wolf, MP Heringa, A Mantingh: Nuchal translucency cannot be used as a screening test for chromosomal abnormalities in the first trimester of pregnancy in a routine ultrasound practice. Prenat Diagn 17 (1997) 785
7. Monni G, MA Zoppi, RM Ibba, M Floris: Fetal nuchal translucency test for Down's syndrome. Lancet 350 (1997) 1631
8. Neilson JP: Assessment of fetal nuchal translucency test for Down's syndrome. Lancet 350 (1997) 754
9. Nicolaides KH, G Azar, D Byrne, C Mansur, K Marks: Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 304 (1992) 867
10. Nicolaides KH, NJ Sebire, RJM Snijders, S Johnson: Down's screening in the UK. Lancet 347 (1996) 906
11. Pandya PP, DG Altman, ML Brizot, H Pettersen, KH Nicolaides: Repeatability of measurement of fetal translucency thickness. Ultrasound Obstet Gynecol 5 (1995) 334
12. Pandya PP, RJM Snijders, SP Johnson, M De Lourdes Brizot, KH Nicolaides: Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 102 (1995) 957
13. Roberts LJ, S Bewley, AM Mackinson, CH Rodeck: First trimester nuchal translucency: Problems with screening the general population I. Br J Obstet Gynaecol 102 (1995) 381
14. Seeds JW: Ultrasonographic screening for fetal aneuploidy. N Engl J Med 337 (1997) 1689
15. Snijders RJM, W Holzgreve, H Cuckle, KH Nicolaides: Maternal age-specific risks for trisomies at 9-14 weeks' gestation. Prenat Diagn 14 (1994) 543
16. Snijders RJM, SP Johnson, NJ Sebire, PL Noble, KH Nicolaides: First-trimester ultrasound screening for chromosomal defects. Ultrasound Obstet Gynecol 7 (1996) 216
17. Szabo J, J Gellen: Nuchal fluid accumulation in trisomy 21 detected by vaginosonography in first trimester. Lancet 336 (1990) 1133
18. Whittle M: Ultrasonographic "soft markers" of fetal chromosomal defects. Br Med J 314 (1997) 918